[go: up one dir, main page]

TR200002761T2 - HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri. - Google Patents

HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri.

Info

Publication number
TR200002761T2
TR200002761T2 TR2000/02761T TR200002761T TR200002761T2 TR 200002761 T2 TR200002761 T2 TR 200002761T2 TR 2000/02761 T TR2000/02761 T TR 2000/02761T TR 200002761 T TR200002761 T TR 200002761T TR 200002761 T2 TR200002761 T2 TR 200002761T2
Authority
TR
Turkey
Prior art keywords
compounds
treatment
substituted
triazine derivatives
hiv infections
Prior art date
Application number
TR2000/02761T
Other languages
English (en)
Inventor
Frans Desire Daeyaert Frederik
De Corte Bart
Rene De Jonge Marc
Heeres Jan
Yung Ho Chin
Adriaan Jan Janssen Paul
W.Kavash Robert
Maria Henricus Koymans Lucien
Joseph Kukla Michael
William Ludovici Donald
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200002761T2 publication Critical patent/TR200002761T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/50—Two nitrogen atoms with a halogen atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/66—Derivatives of melamine in which a hetero atom is directly attached to a nitrogen atom of melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Bu bulus, (I) formülün bilesikleri, bu bilesiklerin N-oksitleri, farmasötik açidan kabul edilebilir ilave tuzlari ve stereokimyasal açidan izomerik biçimlerinin HIV (Insan Bagisiklik-eksikligi Virüsü) enfeksiyonundan musdarip sujelerin tedavisi için bir tibbi maddenin imalati için kullanimina iliskindir. Bulus, bundan baska, (I) formülü bilesiklerinin bir alt-grubu olan yeni bilesiklere, bu bilesiklerin hazirlanmasi ve bu bilesikleri içeren farmasötik bilesimlere iliskindir.
TR2000/02761T 1998-03-27 1999-03-24 HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri. TR200002761T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7963398P 1998-03-27 1998-03-27
EP98201589A EP0945447A1 (en) 1998-03-27 1998-05-14 Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections

Publications (1)

Publication Number Publication Date
TR200002761T2 true TR200002761T2 (tr) 2001-01-22

Family

ID=22151790

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02761T TR200002761T2 (tr) 1998-03-27 1999-03-24 HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri.

Country Status (32)

Country Link
US (3) US6150360A (tr)
EP (2) EP0945447A1 (tr)
JP (1) JP2002511390A (tr)
KR (1) KR100593396B1 (tr)
CN (1) CN1157386C (tr)
AP (1) AP1475A (tr)
AR (1) AR018169A1 (tr)
AT (1) ATE295355T1 (tr)
AU (1) AU758624C (tr)
BG (1) BG64903B1 (tr)
BR (1) BR9909197A (tr)
CA (1) CA2324921C (tr)
DE (1) DE69925256T2 (tr)
DK (1) DK1066269T3 (tr)
EA (1) EA004540B1 (tr)
EE (1) EE200000535A (tr)
ES (1) ES2243056T3 (tr)
HR (1) HRP20000621A2 (tr)
HU (1) HUP0101372A3 (tr)
ID (1) ID26043A (tr)
IL (1) IL138670A (tr)
NO (1) NO317425B1 (tr)
NZ (1) NZ506787A (tr)
OA (1) OA11493A (tr)
PL (1) PL194660B1 (tr)
PT (1) PT1066269E (tr)
SI (1) SI1066269T1 (tr)
SK (1) SK14052000A3 (tr)
TR (1) TR200002761T2 (tr)
TW (1) TW570917B (tr)
WO (1) WO1999050256A1 (tr)
ZA (1) ZA200006042B (tr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
DE60025837T2 (de) * 1999-09-24 2006-11-02 Janssen Pharmaceutica N.V. Antivirale feste dispersionen
US6645964B1 (en) * 1999-11-29 2003-11-11 Aventis Pharma S.A. Chemical derivatives and their application as antitelomerase agent
US6906067B2 (en) * 1999-12-28 2005-06-14 Bristol-Myers Squibb Company N-heterocyclic inhibitors of TNF-α expression
US20020065270A1 (en) * 1999-12-28 2002-05-30 Moriarty Kevin Joseph N-heterocyclic inhibitors of TNF-alpha expression
US6943161B2 (en) * 1999-12-28 2005-09-13 Pharmacopela Drug Discovery, Inc. Pyrimidine and triazine kinase inhibitors
EP1282607B1 (en) 2000-05-08 2015-11-11 Janssen Pharmaceutica NV Prodrugs of hiv replication inhibiting pyrimidines
JP5230050B2 (ja) 2000-05-08 2013-07-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｈｉｖ複製阻害剤
US6858608B2 (en) * 2001-01-09 2005-02-22 Aventis Pharma S.A. Chemical derivatives and their application as antitelomerase agents
US6887873B2 (en) * 2001-03-23 2005-05-03 Aventis Pharma S.A. Triazine derivatives and their application as antitelomerase agents
US6958211B2 (en) 2001-08-08 2005-10-25 Tibotech Bvba Methods of assessing HIV integrase inhibitor therapy
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US7169785B2 (en) * 2001-09-21 2007-01-30 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
US7163943B2 (en) * 2001-09-21 2007-01-16 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
US7112587B2 (en) * 2001-09-21 2006-09-26 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
IL160984A0 (en) * 2001-09-21 2004-08-31 Reddy Us Therapeutics Inc Triazine derivatives and pharmaceutical compositions containing the same
US7132423B2 (en) * 2001-09-21 2006-11-07 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
EP1441683A4 (en) * 2001-10-12 2005-10-26 Univ New York TRISUBSTITUTED TRIAZIN COMPOUNDS AND METHOD FOR THE PREPARATION AND USE OF THE COMPOUNDS WITH ANTITUBULIN EFFECT
US7291616B2 (en) 2001-10-31 2007-11-06 Cell Therapeutics, Inc. Aryl triazines as LPAAT-β inhibitors and uses thereof
KR100875362B1 (ko) 2002-02-05 2008-12-22 아스텔라스세이야쿠 가부시키가이샤 2,4,6-트리아미노-1,3,5-트리아진 유도체
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
CN1747941A (zh) * 2003-02-07 2006-03-15 詹森药业有限公司 抑制hiv的1,2,4－三嗪
US20070232572A1 (en) * 2003-02-07 2007-10-04 Aventis Pharma S.A. Chemical derivatives as antitelomerase agents which bind specifically to the G-quadruplex DNA structures and their application as a specific anticancer agent
CL2004000306A1 (es) * 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
US6875781B2 (en) * 2003-04-04 2005-04-05 Cell Therapeutics, Inc. Pyridines and uses thereof
ES2667668T3 (es) 2003-07-17 2018-05-14 Janssen Sciences Ireland Uc Procedimiento para preparar partículas que contienen un antiviral
JP2006528640A (ja) * 2003-07-22 2006-12-21 ニューロジェン・コーポレーション 置換ピリジン−２−イルアミン類縁体
US7335770B2 (en) * 2004-03-24 2008-02-26 Reddy U5 Therapeutics, Inc. Triazine compounds and their analogs, compositions, and methods
ES2442857T3 (es) * 2004-08-10 2014-02-13 Janssen Pharmaceutica Nv Derivados de 1,2,4-triazin-6-ona inhibidores de VIH
MX2007003797A (es) 2004-09-30 2007-04-23 Tibotec Pharm Ltd 5-heterociclil pirimidinas inhibidoras del virus de inmunodeficiencia humana.
CA2573976C (en) 2004-09-30 2014-04-29 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
EP1797047B1 (en) 2004-09-30 2012-01-25 Tibotec Pharmaceuticals Hiv inhibiting 5-substituted pyrimidines
KR20070085286A (ko) 2004-10-29 2007-08-27 티보텍 파마슈티칼즈 리미티드 Ｈｉｖ를 저해하는 바이사이클릭 피리미딘 유도체
US7592451B2 (en) * 2005-06-23 2009-09-22 New York University Treatment for diabetes and obesity as well as method of screening compounds useful for such treatments
CN101245051B (zh) * 2005-12-22 2011-04-20 中国科学院上海药物研究所 2，4-二取代氨基-6-取代-[1，3，5]三嗪类化合物、其制备方法、药物组合物及用途
BRPI0709690B8 (pt) 2006-03-30 2021-05-25 Janssen R & D Ireland 5-amido pirimidinas substituídas e composição farmacêutica que as compreende
CN101573342A (zh) 2006-12-29 2009-11-04 泰博特克药品有限公司 抑制hiv的5,6-取代的嘧啶类化合物
KR20090094073A (ko) 2006-12-29 2009-09-03 티보텍 파마슈티칼즈 리미티드 Ｈｉｖ를 억제하는 6-치환된 피리미딘
CA2814120C (en) 2010-10-27 2018-08-07 The Walter And Eliza Hall Institute Of Medical Research Novel anti-cancer agents
GB201119358D0 (en) 2011-11-10 2011-12-21 Lewi Paulus J Disubstituted triazine dimers for treatment and/or prevention of infectious diseases
GB201204756D0 (en) 2012-03-19 2012-05-02 Lewi Paulus J Triazines with suitable spacers for treatment and/or prevention of HIV infections
WO2014072419A1 (en) 2012-11-08 2014-05-15 Universiteit Antwerpen Novel anti-hiv compounds
US9914709B2 (en) * 2013-06-21 2018-03-13 Yale University Compositions and methods of treating HIV-1 infections using same
US20170101383A1 (en) * 2014-03-28 2017-04-13 Basf Se Diaminotriazine derivatives as herbicides
JP6938510B2 (ja) * 2015-12-24 2021-09-22 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア Ｃｆｔｒ制御因子及びこの使用方法
US11839616B2 (en) 2017-08-24 2023-12-12 The Regents Of The University Of California Ocular pharmaceutical compositions
CN109053613A (zh) * 2018-07-04 2018-12-21 复旦大学 含有联苯结构的二芳基三嗪类化合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2742466A (en) * 1956-04-17 Chx n nhx c c
US2671810A (en) * 1952-05-24 1954-03-09 Du Pont Long-chain diketones
BE754242A (fr) * 1970-07-15 1971-02-01 Geigy Ag J R Diamino-s-triazines et dinitro-s-triazines
US4096206A (en) 1976-02-09 1978-06-20 Borg-Warner Corporation Flame-retardant triazines
US4652645A (en) 1983-11-16 1987-03-24 Ciba-Geigy Corporation Cationic compounds
EP0541966A3 (en) * 1991-11-15 1994-09-07 American Cyanamid Co Process for preparing amide derivatives from halomines and acid halides
US5283274A (en) * 1992-06-19 1994-02-01 Uniroyal Chemical Company, Inc. Substituted pyrimidines and substituted triazines as rubber-to-metal adhesion promoters
NZ274978A (en) 1993-10-12 1998-04-27 Du Pont Merck Pharma 1n-alkyl-n-aryl pyrimidinamine derivatives and pharmaceutical compositions thereof
GB9519197D0 (en) * 1995-09-20 1995-11-22 Affinity Chromatography Ltd Novel affinity ligands and their use
CN1163401A (zh) * 1996-02-13 1997-10-29 李占元 全自动血球计数仪试剂及配制方法
WO1999036410A1 (en) * 1998-01-13 1999-07-22 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds

Also Published As

Publication number Publication date
CN1295566A (zh) 2001-05-16
CA2324921C (en) 2009-05-12
EE200000535A (et) 2002-04-15
US20020115668A1 (en) 2002-08-22
US6372729B1 (en) 2002-04-16
HRP20000621A2 (en) 2001-04-30
EA200000993A1 (ru) 2001-04-23
HUP0101372A3 (en) 2003-02-28
BG104716A (en) 2001-04-30
US6774235B2 (en) 2004-08-10
PT1066269E (pt) 2005-09-30
JP2002511390A (ja) 2002-04-16
HUP0101372A2 (hu) 2001-10-28
HK1032394A1 (en) 2001-07-20
AR018169A1 (es) 2001-10-31
OA11493A (en) 2004-05-07
SK14052000A3 (sk) 2001-06-11
EA004540B1 (ru) 2004-06-24
KR20010034270A (ko) 2001-04-25
AU758624C (en) 2004-03-11
NZ506787A (en) 2003-02-28
AP1475A (en) 2005-10-03
PL343195A1 (en) 2001-07-30
BR9909197A (pt) 2000-12-05
WO1999050256A1 (en) 1999-10-07
BG64903B1 (bg) 2006-08-31
AU758624B2 (en) 2003-03-27
NO20004809D0 (no) 2000-09-26
ZA200006042B (en) 2001-10-26
DE69925256D1 (de) 2005-06-16
AU3599799A (en) 1999-10-18
TW570917B (en) 2004-01-11
EP1066269B1 (en) 2005-05-11
US6150360A (en) 2000-11-21
DE69925256T2 (de) 2006-02-23
NO317425B1 (no) 2004-10-25
ATE295355T1 (de) 2005-05-15
ES2243056T3 (es) 2005-11-16
AP2000001913A0 (en) 2000-09-30
KR100593396B1 (ko) 2006-06-28
CN1157386C (zh) 2004-07-14
ID26043A (id) 2000-11-16
CA2324921A1 (en) 1999-10-07
PL194660B1 (pl) 2007-06-29
EP1066269A1 (en) 2001-01-10
NO20004809L (no) 2000-11-24
DK1066269T3 (da) 2005-09-05
EP0945447A1 (en) 1999-09-29
IL138670A (en) 2005-12-18
SI1066269T1 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
TR200002761T2 (tr) HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri.
TR200002760T2 (tr) HIV engelleyici pirimidin türevleri
TR200101306T2 (tr) HİV Virüsünün çoğalmasını önleyen pirimidinler
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
NO20052739L (no) CCR5-antagonister som medikamenter
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
MY146279A (en) Compounds affecting glucokinase
HUP0002224A1 (hu) Virusellenes hatású benzimidazol-származékok
EA200600225A1 (ru) Производные пиперазина для лечения вич инфекций
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
MA26488A1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
TR199701647A2 (tr) Ikame edilmis purin türevleri,bunlarin imalat usulü
TR199900732T2 (tr) PDE IV inhibe eden 2-siyanoiminoimidazol türevleri.
DE60001586D1 (de) Diphenyl-piperidin derivate
BR9912142A (pt) 6-benzil-4-oxipirimidinas substituìdas, processopara sua preparação e composições contendo-as
NO20032261L (no) Medisinske preparater
TR199902094T2 (tr) 3-Heteroareil-4(3H)-kinazolinonlarin atropizomerleri.
TR200002801T2 (tr) PDE IV engelleyici piridin türevleri
TR200101319T2 (tr) 2,4-Disübstitüe triazin türevleri.
DE60204967D1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
TR200101813T2 (tr) Alfa2-Antagonistleri olarak benzisoksazoller ve fenonlar